-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SP9j8k1c/0whkDdX2pZcL3qbKm5pk5oGG4hdt0cQ1uFv5MAJyZ+ofFDTXh+tnq7f YQIz/ZrTlB8K0iy6Lh4oMw== 0001144204-08-049213.txt : 20080821 0001144204-08-049213.hdr.sgml : 20080821 20080821165055 ACCESSION NUMBER: 0001144204-08-049213 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080815 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080821 DATE AS OF CHANGE: 20080821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VELCERA, INC. CENTRAL INDEX KEY: 0001344300 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 203327015 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51622 FILM NUMBER: 081032668 BUSINESS ADDRESS: STREET 1: 777 TOWNSHIP LINE ROAD, SUITE 170 CITY: YARDLEY STATE: PA ZIP: 19067-5508 BUSINESS PHONE: (267) 757-3600 MAIL ADDRESS: STREET 1: 777 TOWNSHIP LINE ROAD, SUITE 170 CITY: YARDLEY STATE: PA ZIP: 19067-5508 FORMER COMPANY: FORMER CONFORMED NAME: DENALI SCIENCES, INC. DATE OF NAME CHANGE: 20051114 8-K 1 v124589_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 15, 2008

Velcera, Inc.
(Exact Name of registrant as specified in its charter)

Delaware
 
 000-51622
  
20-3327015
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)

777 Township Line Road, Suite 170
Yardley, Pennsylvania 19067
(Address of Principal Executive Offices) (Zip Code)
 
(267) 757-3600
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective December 15, 2008, Dr. Antonio Benitz will no longer serve as Vice President of Research and Development of Velcera, Inc. (the “Company”). By mutual agreement, the Company and Dr. Benitz entered into a Separation Agreement and General Release (“Separation and Release Agreement”).

The Settlement and Release Agreement will provide Dr. Benitz the full vesting of all outstanding options if Dr. Benitz remains with the Company through December 15, 2008. Dr. Benitz released the Company from any further obligations related to his departure.

 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  VELCERA, INC.
 
 		  
 		  
 
Date: August 21, 2008 By:   /s/ Matthew C. Hill
 
Matthew C. Hill
  Chief Financial Officer
 



 
 
 
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----